MGLKX | MGLMX | MGLKX / MGLMX | |
Total Expense Ratio | 1.44 | 0.94 | 153% |
Annual Report Gross Expense Ratio | 1.45 | 0.95 | 153% |
Fund Existence | 10 years | 10 years | - |
Gain YTD | 2.110 | 2.304 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.29B | 2.29B | 100% |
Annual Yield % from dividends | 1.87 | 2.53 | 74% |
Returns for 1 year | 4.89 | 5.43 | 90% |
Returns for 3 years | -11.30 | -9.94 | 114% |
Returns for 5 years | 16.13 | 19.10 | 84% |
Returns for 10 years | 14.22 | 20.04 | 71% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 61.07 | 0.16 | +0.26% |
Janus Henderson Global Life Sciences S | |||
NQGCX | 37.97 | 0.07 | +0.18% |
Nuveen Global Equity Income C | |||
BEGIX | 21.60 | 0.03 | +0.14% |
Sterling Capital Equity Income Instl | |||
FERIX | 53.01 | -0.44 | -0.82% |
Fidelity Advisor Emerging Asia I | |||
EEMIX | 8.56 | -0.09 | -1.04% |
MFS Emerging Markets Equity Research I |